These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12792831)

  • 1. [Social skills training in psychosocial therapy of schizophrenia: a multicenter study for symptom management and medication management modules].
    Yildiz M; Yazici A; Unal S; Aker T; Ozgen G; Ekmekçi H; Duy B; Torun F; Unsal G; Coşkun S; Sipahi B; Cakil G; Eryildiz M
    Turk Psikiyatri Derg; 2002; 13(1):41-7. PubMed ID: 12792831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-management plans for asthma control and predictors of patient compliance.
    Kaya Z; Erkan F; Ozkan M; Ozkan S; Kocaman N; Ertekin BA; Direk N
    J Asthma; 2009 Apr; 46(3):270-5. PubMed ID: 19373635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral rehabilitation for chronic mental patients.
    Liberman RP; Evans CC
    J Clin Psychopharmacol; 1985 Jun; 5(3 Suppl):8S-14S. PubMed ID: 2860141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What impedes discharge support for persons with schizophrenia in psychiatric hospitals?].
    Ikebuchi E; Satoh S; Anzai N
    Seishin Shinkeigaku Zasshi; 2008; 110(11):1007-22. PubMed ID: 19202923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An Experience of a Clubhouse run by Families and Volunteers for Schizophrenia Rehabilitation].
    Yildiz M; Tural U; Kurdoğlu S; Emin Onder M
    Turk Psikiyatri Derg; 2003; 14(4):281-7. PubMed ID: 14704930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life of schizophrenia patients and health related problem solving skills--comparison between the group of patient participated in social skills training and psychoeducation group].
    Kasperek B; Spiridonow K; Chadzyńska M; Meder J
    Psychiatr Pol; 2002; 36(5):717-30. PubMed ID: 12491982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study.
    Hutchison LC; Jones SK; West DS; Wei JY
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):144-53. PubMed ID: 16860261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of 3-year psychiatric daycare treatment in patients with schizophrenia.
    Inadomi H; Tanaka G; Watanabe S; Nagatomi Y; Mitarai K; Ohsawa R; Kusumeki K; Shimatani T; Hatanaka K; Hiroike T; Teramoto K; Utsunomiya H; Etoh R; Ohta Y
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):246-52. PubMed ID: 15896216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.